1. Home
  2. KPTI vs SQNS Comparison

KPTI vs SQNS Comparison

Compare KPTI & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.41

Market Cap

172.6M

Sector

Health Care

ML Signal

HOLD

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$3.28

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPTI
SQNS
Founded
2008
2003
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.6M
85.3M
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
KPTI
SQNS
Price
$8.41
$3.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$17.50
$20.33
AVG Volume (30 Days)
620.8K
74.7K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$146,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$46.62
$62.85
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$3.51
$0.73
52 Week High
$10.99
$10.93

Technical Indicators

Market Signals
Indicator
KPTI
SQNS
Relative Strength Index (RSI) 49.70 47.62
Support Level $5.60 $2.72
Resistance Level $8.95 $5.85
Average True Range (ATR) 0.75 0.17
MACD -0.18 0.09
Stochastic Oscillator 40.07 92.73

Price Performance

Historical Comparison
KPTI
SQNS

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: